How is hormone replacement therapy different in women over 40?

Women over 40 may be in perimenopause, have reached menopause, or have menopause earlier than expected. Symptoms can include hot flushes, night sweats, sleep disruption, vaginal dryness, and changes in bleeding. The timing and pattern help a clinician decide whether hormones are appropriate and which form may fit.

Treatment choices depend on whether the uterus is present, because oestrogen alone may not be suitable when the uterine lining needs protection. A clinician also reviews migraine, blood clots, liver disease, unexplained bleeding, breast or hormone-sensitive cancer history, and cardiovascular risk. Local vaginal treatment and whole-body treatment have different purposes and exposure patterns.

Record symptoms, bleeding dates, medicines, and personal or family health history before your appointment. Discuss the lowest treatment exposure that meets your goals, the route of delivery, and whether you need a progestogen alongside oestrogen. Review the plan after starting and report unexpected bleeding rather than stopping or continuing treatment without advice.

HRT is not contraception. If pregnancy is possible, ask about contraception separately. Lifestyle measures, non-hormonal medicines, lubricants, or moisturisers may also help, depending on the symptom. The right option can change as symptoms and health circumstances change.

Arrange medical review for bleeding after menopause, bleeding that is heavy or persistent, a new breast change, leg swelling or pain, chest pain, sudden breathlessness, or a severe new headache. Seek urgent help for sudden weakness, trouble speaking, or collapse. These symptoms need assessment whether or not you use HRT.

Ask which menopause stage you may be in, what symptom the treatment is intended to address, whether you need uterine protection, and which route is suitable. Ask how your migraine or clot history changes the discussion, when bleeding should be reviewed, and how often the plan should be reassessed.